Ifp Advisors, Inc Petros Pharmaceuticals, Inc. Transaction History

Ifp Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$1.82 - $3.2 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$2.87 - $4.11 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	SELL	$2.85 - $4.6 $2,280 - $3,679	-800 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$3.24 - $4.68 $2,592 - $3,744	800 New	800 $4,000

Ticker PTPI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,708,000
Market Cap $6.42M
Description
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for th...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.